1. Home
  2. CVAC vs AIV Comparison

CVAC vs AIV Comparison

Compare CVAC & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • AIV
  • Stock Information
  • Founded
  • CVAC 2000
  • AIV 1975
  • Country
  • CVAC Germany
  • AIV United States
  • Employees
  • CVAC N/A
  • AIV N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • AIV Real Estate Investment Trusts
  • Sector
  • CVAC Health Care
  • AIV Real Estate
  • Exchange
  • CVAC Nasdaq
  • AIV Nasdaq
  • Market Cap
  • CVAC 1.2B
  • AIV 1.2B
  • IPO Year
  • CVAC 2020
  • AIV 1994
  • Fundamental
  • Price
  • CVAC $5.36
  • AIV $5.55
  • Analyst Decision
  • CVAC Hold
  • AIV Buy
  • Analyst Count
  • CVAC 3
  • AIV 1
  • Target Price
  • CVAC $6.83
  • AIV $10.00
  • AVG Volume (30 Days)
  • CVAC 411.0K
  • AIV 2.3M
  • Earning Date
  • CVAC 11-11-2025
  • AIV 11-06-2025
  • Dividend Yield
  • CVAC N/A
  • AIV 51.17%
  • EPS Growth
  • CVAC N/A
  • AIV N/A
  • EPS
  • CVAC 1.01
  • AIV N/A
  • Revenue
  • CVAC $599,540,810.00
  • AIV $212,439,000.00
  • Revenue This Year
  • CVAC N/A
  • AIV $6.96
  • Revenue Next Year
  • CVAC $23.83
  • AIV N/A
  • P/E Ratio
  • CVAC $5.34
  • AIV N/A
  • Revenue Growth
  • CVAC 675.15
  • AIV 7.07
  • 52 Week Low
  • CVAC $2.37
  • AIV $5.49
  • 52 Week High
  • CVAC $5.72
  • AIV $9.29
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 45.73
  • AIV 17.88
  • Support Level
  • CVAC $5.34
  • AIV $7.49
  • Resistance Level
  • CVAC $5.41
  • AIV $8.01
  • Average True Range (ATR)
  • CVAC 0.04
  • AIV 0.18
  • MACD
  • CVAC -0.00
  • AIV -0.20
  • Stochastic Oscillator
  • CVAC 18.18
  • AIV 2.78

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

Share on Social Networks: